• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.

作者信息

Moctezuma Sananda I, Panizo Carlos M, Landecho Manuel F

机构信息

Departamento de Medicina Interna, Clínica Universitaria de Navarra, Pamplona, Navarra, España.

Departamento de Hematología, Clínica Universitaria de Navarra, Pamplona, Navarra, España.

出版信息

Med Clin (Barc). 2017 Oct 11;149(7):312-313. doi: 10.1016/j.medcli.2017.05.041. Epub 2017 Jul 21.

DOI:10.1016/j.medcli.2017.05.041
PMID:28736065
Abstract
摘要

相似文献

1
Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.利妥昔单抗和硫唑嘌呤联合方案成功治疗常见可变免疫缺陷相关的肉芽肿性和淋巴细胞性间质性肺病
Med Clin (Barc). 2017 Oct 11;149(7):312-313. doi: 10.1016/j.medcli.2017.05.041. Epub 2017 Jul 21.
2
Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.常见可变免疫缺陷患者的肉芽肿性淋巴细胞间质性肺病的管理
BMJ Case Rep. 2016 Jun 22;2016:bcr2016215624. doi: 10.1136/bcr-2016-215624.
3
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.利妥昔单抗和抗代谢药物治疗普通变异性免疫缺陷中的肉芽肿性和淋巴细胞性间质性肺病。
J Allergy Clin Immunol. 2021 Feb;147(2):704-712.e17. doi: 10.1016/j.jaci.2020.07.021. Epub 2020 Aug 1.
4
Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency.利妥昔单抗单药治疗常见可变免疫缺陷中的肉芽肿性淋巴细胞间质性肺病
J Investig Allergol Clin Immunol. 2019 Dec;29(6):470-471. doi: 10.18176/jiaci.0450.
5
Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.血清白细胞介素-12和可溶性白细胞介素-2受体水平作为常见可变免疫缺陷中肉芽肿性和淋巴细胞性间质性肺病的潜在生物标志物：病例报告
J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):273-6. doi: 10.1016/j.jaip.2014.09.019. Epub 2014 Nov 25.
6
Successful rituximab treatment of granulomatous/lymphocytic interstitial lung disease in common variable immunodeficiency.利妥昔单抗成功治疗常见可变免疫缺陷中的肉芽肿性/淋巴细胞间质性肺病。
Epidemiol Mikrobiol Imunol. 2018 Winter;67(3):142-148.
7
Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency.利妥昔单抗单药治疗常见可变免疫缺陷患者肉芽肿性和淋巴细胞性间质性肺病的疗效。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):1055-1057.e2. doi: 10.1016/j.jaip.2018.10.041. Epub 2018 Nov 5.
8
Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency.利妥昔单抗单药成功治疗一名患有常见变异型免疫缺陷的儿科患者的肉芽肿性淋巴细胞间质性肺病。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):876-878.e1. doi: 10.1016/j.jaip.2021.10.040. Epub 2021 Oct 27.
9
Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.利妥昔单抗单药治疗常见可变免疫缺陷相关的肉芽肿性淋巴细胞性间质性肺病。
Chest. 2019 May;155(5):e117-e121. doi: 10.1016/j.chest.2019.01.034.
10
Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.利妥昔单抗单药治疗作为 CVID 患者肉芽肿性淋巴细胞性间质性肺病 (GLILD) 的一线治疗是有效的。
J Clin Immunol. 2023 Nov;43(8):2091-2103. doi: 10.1007/s10875-023-01587-4. Epub 2023 Sep 27.